 |
STEMCELL LAB CORP
is a client-based cell therapy services company that supports the development of cellular therapies by providing cGMP-compliant cell manufacturing and consulting services that address regulatory, financial, technical, process, and quality systems strategies.
SCLC's cG(x)P USA and international network enables it to provide a full spectrum of support including preclinical development, clinical research, collection, processing, tissue storage, diagnostics/biologic product testing, manufacturing, distribution and transportation.
|
|
 |
Overview |
|
STEMCELL LAB CORP services are applicable throughout the entire field of cell therapy. The cell therapy market is experiencing rapid growth, and according to industry reports, the value of the 2005's international cell therapy market was estimated to be $26.6 billion. It has been projected that the market will reach $56.2 billion in 2010 and $96.3 billion in 2015*.
|
|
Our Corporate Values |
|
Our values are rooted in the knowledge that the products we manufacture and the services we provide affect the quality of patients' lives. Since everything we do, no matter how small, impacts the end product, we demand the highest ethical and quality standards, both from ourselves and others. These values drive us to achieve excellence and build quality in absolutely everything we do.
|
|
Focus and Commitment
• From bench to market: advancing clients in the field of cellular therapy
|
Unparalleled Expertise
• Management team with extensive experience in cell-based therapeutics
|
|
State-of-the-art cG(x)P Facilities
• Fully licensed and outsourcing contract manufacturing facilities located in the USA, Europe and Asia.
|
Regulatory Leadership
• Experience working with US and international regulatory authorities
|
|
National Coverage
• Air and ground transportation networks that provide 24/7 processing and delivery options
|
Extensive Industry Network
• SCLC's clients represent the industry's leaders in cell-based product development, research and patient care.
|
|
|
|
|
